Log in

NASDAQ:RMTI - Rockwell Medical Stock Price, Forecast & News

$2.90
+0.36 (+14.17 %)
(As of 02/19/2020 09:01 AM ET)
Today's Range
$2.55
Now: $2.90
$2.98
50-Day Range
$2.12
MA: $2.49
$2.90
52-Week Range
$1.81
Now: $2.90
$6.88
Volume2.50 million shs
Average Volume791,568 shs
Market Capitalization$185.48 million
P/E RatioN/A
Dividend YieldN/A
Beta1.54
Rockwell Medical, Inc operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:RMTI
CUSIP77437410
Phone248-960-9009

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$63.39 million
Book Value$0.48 per share

Profitability

Net Income$-32,130,000.00

Miscellaneous

Employees269
Market Cap$185.48 million
Next Earnings Date3/12/2020 (Estimated)
OptionableOptionable

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.


Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How were Rockwell Medical's earnings last quarter?

Rockwell Medical Inc (NASDAQ:RMTI) issued its earnings results on Monday, November, 11th. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02. The company had revenue of $15.41 million for the quarter, compared to the consensus estimate of $15.40 million. Rockwell Medical had a negative return on equity of 139.38% and a negative net margin of 57.77%. View Rockwell Medical's Earnings History.

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Rockwell Medical.

What price target have analysts set for RMTI?

4 brokers have issued twelve-month target prices for Rockwell Medical's shares. Their forecasts range from $6.00 to $11.00. On average, they anticipate Rockwell Medical's stock price to reach $9.33 in the next year. This suggests a possible upside of 221.8% from the stock's current price. View Analyst Price Targets for Rockwell Medical.

What is the consensus analysts' recommendation for Rockwell Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rockwell Medical.

Has Rockwell Medical been receiving favorable news coverage?

Press coverage about RMTI stock has been trending very positive recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Rockwell Medical earned a news impact score of 3.5 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View News Stories for Rockwell Medical.

Who are some of Rockwell Medical's key competitors?

What other stocks do shareholders of Rockwell Medical own?

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the folowing people:
  • Mr. Stuart Paul, Pres, CEO & Director (Age 59)
  • Mr. Angus W. Smith, Chief Financial Officer (Age 36)
  • Dr. Ajay Gupta, Chief Scientific Officer & Member of Scientific Advisory Board (Age 61)
  • Mr. Michael DeYoung, VP of Operations
  • Mr. David J. Kull, Principal Accounting Officer, Sec. & Controller (Age 51)

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (1.63%), Perkins Capital Management Inc. (1.16%), SkyOak Wealt LLC (0.39%), Bank of New York Mellon Corp (0.34%), Perritt Capital Management Inc. (0.14%) and UBS Group AG (0.14%). Company insiders that own Rockwell Medical stock include Angus W Smith, David S Richmond and Stuart M Paul. View Institutional Ownership Trends for Rockwell Medical.

Which major investors are selling Rockwell Medical stock?

RMTI stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., State Street Corp, Bank of America Corp DE, Perritt Capital Management Inc., Bank of New York Mellon Corp, Citigroup Inc. and Raymond James & Associates. View Insider Buying and Selling for Rockwell Medical.

Which major investors are buying Rockwell Medical stock?

RMTI stock was purchased by a variety of institutional investors in the last quarter, including SkyOak Wealt LLC, Banco Bilbao Vizcaya Argentaria S.A., Renaissance Technologies LLC, UBS Group AG, Virtu Financial LLC, California Public Employees Retirement System, SG Americas Securities LLC and Prudential Financial Inc.. Company insiders that have bought Rockwell Medical stock in the last two years include Angus W Smith, David S Richmond and Stuart M Paul. View Insider Buying and Selling for Rockwell Medical.

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $2.90.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $185.48 million and generates $63.39 million in revenue each year. The company earns $-32,130,000.00 in net income (profit) each year or ($0.47) on an earnings per share basis. Rockwell Medical employs 269 workers across the globe.View Additional Information About Rockwell Medical.

What is Rockwell Medical's official website?

The official website for Rockwell Medical is http://www.rockwellmed.com/.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The company can be reached via phone at 248-960-9009 or via email at [email protected]


MarketBeat Community Rating for Rockwell Medical (NASDAQ RMTI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  267 (Vote Outperform)
Underperform Votes:  293 (Vote Underperform)
Total Votes:  560
MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel